Farms.com Home   News

Huge Backlog Pressures Slaughter Hog Values

The Director of Risk Management with HAMS Marketing Services says a massive year over year increase in the number of hogs available in the U.S. for slaughter continues to pressure North American live hog values. USDA released its quarterly hogs and pigs report last week.
 
Tyler Fulton, the Director of Risk Management with HAMS Marketing Services, says the backlog of hogs due to COVID-19 continues to impact prices.
 
Clip-Tyler Fulton-HAMS Marketing Services:
 
I think probably the biggest take away from the report was some pretty massive numbers, year over year increases in the heaviest market weight categories. What we're talking about is the hogs that are going to be coming to market over the next two months or so. Those year over year increases were in the double digits, were over 10 percent larger than year ago levels.
 
It's been 20 years since we've seen any year over year change of that magnitude. But, when you think back to what we've just dealt with over the course of the last two months, they were taking these surveys just two or three after the lowest slaughter capacity. When we had the plants go down in the United States that were dealing with COVID-19 through their labour force, they effectively cut the U.S. slaughter by one third.
 
So just two or three weeks later the hog producers that were answering the survey were responding to the questions in exactly the way that they would normally and that meant that all of that backlog of hogs that weren't getting slaughtered, they were reporting on. I think that that had probably skewed some of those numbers in a pretty big way that we simply still need to work through over the course of the next two months or so.
Source : Farmscape

Trending Video

A new era in biostimulants and bionutritionals

Video: A new era in biostimulants and bionutritionals


In response to the growing need for efficient, effective biosolutions, HGS BioScience continues to expand its footprint in the bionutritional and biostimulant market with the acquisition of NutriAg, Ltd. The Paine Schwartz Partners-backed HGS BioScience is a global leader in humic and fulvic acid products. Toronto-based NutriAg is an innovator in bionutritional technologies with a deep R&D engine. North American growers and retailers will benefit from:

• Solutions across the biostimulant spectrum - including humics, fulvics, bionutritionals, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
• A portfolio and R&D pipeline of science-backed solutions proven to drive crop productivity and farm profitability.
• Actionable nutrient insights and recommendations based on data specific to their farm and cropping goals with the NutriAnalytics platform